- Home
- ABOS vs PRE Comparison
ABOS vs PRE Comparison
Compare ABOS & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- PRE
- Stock Information
- Founded
- ABOS 1996
- PRE 2014
- Country
- ABOS United States
- PRE Hong Kong
- Employees
- ABOS N/A
- PRE N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- ABOS Health Care
- PRE Industrials
- Exchange
- ABOS Nasdaq
- PRE Nasdaq
- Market Cap
- ABOS 109.6M
- PRE 131.3M
- IPO Year
- ABOS 2021
- PRE N/A
- Fundamental
- Price
- ABOS $1.55
- PRE $11.82
- Analyst Decision
- ABOS Strong Buy
- PRE Buy
- Analyst Count
- ABOS 3
- PRE 1
- Target Price
- ABOS $8.00
- PRE $32.00
- AVG Volume (30 Days)
- ABOS 275.1K
- PRE 200.8K
- Earning Date
- ABOS 11-12-2025
- PRE 11-10-2025
- Dividend Yield
- ABOS N/A
- PRE N/A
- EPS Growth
- ABOS N/A
- PRE N/A
- EPS
- ABOS N/A
- PRE N/A
- Revenue
- ABOS N/A
- PRE $77,079,000.00
- Revenue This Year
- ABOS N/A
- PRE $202.46
- Revenue Next Year
- ABOS N/A
- PRE $103.60
- P/E Ratio
- ABOS N/A
- PRE N/A
- Revenue Growth
- ABOS N/A
- PRE 201.54
- 52 Week Low
- ABOS $0.86
- PRE $3.10
- 52 Week High
- ABOS $2.66
- PRE $17.99
- Technical
- Relative Strength Index (RSI)
- ABOS 35.12
- PRE 42.53
- Support Level
- ABOS $1.74
- PRE $11.64
- Resistance Level
- ABOS $2.04
- PRE $13.98
- Average True Range (ATR)
- ABOS 0.16
- PRE 1.20
- MACD
- ABOS -0.07
- PRE -0.24
- Stochastic Oscillator
- ABOS 9.20
- PRE 6.22
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.